| Phase 3 |
| NCT06669013 |
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas |
Bone Sarcoma |
Recruiting |
2024-11-01 |
| NCT07258680 |
BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line… |
Peripheral T-cell Lymphoma |
Enrolling by Invitation |
2025-12-02 |
| Phase 2 |
| NCT06418789 |
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors |
Germ Cell Tumor |
Recruiting |
2025-08-03 |
| Not applicable |
| NCT07579286 |
Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast… |
Early Breast Cancer |
Recruiting |
2026-05-12 |
| NCT04293796 |
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete… |
Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB |
Recruiting |
2022-06-15 |
| NCT04330456 |
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative… |
Soft Tissue Sarcoma Adult |
Recruiting |
2020-04-01 |
| NCT07821229 |
Combination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated… |
Breast Cancer (Early Breast Cancer) |
Active, Not Recruiting |
2026-09-15 |
| Not specified |
| NCT07777887 |
Sentinel Node Identification Using Gamma and Near-Infrared Imaging in TesticulAr… |
Germ Cell Tumor of Testis |
Recruiting |
2026-08-27 |
| NCT05539677 |
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical… |
Malignant Solid Tumors |
Recruiting |
2024-05-06 |
| NCT06043947 |
Survival Monitoring in Russian Cancer Registries |
Melanoma |
Active, Not Recruiting |
2026-05-15 |